Anixa Biosciences ANIX
NASDAQ ANIX
$2.95 +0.18 (+6.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Gains from Sales and Divestitures (2020 - 2021)

Updated

Anixa Biosciences (ANIX) posted Gains from Sales and Divestitures of $1,000 for fiscal Q4 2021 (quarter ended Oct 31, 2021), compared with -$296,168 a year earlier.

Analysis

Anixa Biosciences (ANIX) Gains from Sales and Divestitures (2020 - 2021) Analysis & Trends

For FY2021 (ended Oct 31, 2021), Anixa Biosciences' Gains from Sales and Divestitures came in at $6,000.

  • In prior fiscal years, Anixa Biosciences' Gains from Sales and Divestitures was -$148,084 in FY2020 and -$45,915 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Anixa Biosciences 102.02 Mn 100.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2021 1,000.00
Jan 31, 2021 5,000.00
Oct 31, 2020 -296,168.00
API Access

Anixa Biosciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ANIX&period=max&api_key=YOUR_API_KEY